Table 1.
Correlation between miR-3614-5p expression and clinicopathological parameters of CRC
| Clinicopathological parameters | N = 65 | 3614 expression | P value | |
|---|---|---|---|---|
| Low expression | High expression | |||
| n = 32 | n = 33 | |||
| Gender | ||||
| Male | 37 | 20 | 17 | 0.3712 |
| Female | 28 | 12 | 16 | |
| Age | ||||
| <60 | 29 | 11 | 18 | 0.1019 |
| ≥ 60 | 36 | 21 | 15 | |
| Lymph node metastasis | ||||
| Absent | 34 | 13 | 21 | 0.06331 |
| Present | 31 | 19 | 12 | |
| Distant metastasis | ||||
| Absent | 52 | 21 | 31 | 0.004329 |
| Present | 13 | 11 | 2 | |
| Clinical stage | ||||
| I+II | 30 | 10 | 20 | 0.01762 |
| III+IV | 35 | 22 | 13 | |
| T stage | ||||
| T1-2 | 17 | 6 | 11 | 0.1811 |
| T3-4 | 48 | 26 | 22 | |
| Nerve Invasion | ||||
| Absent | 38 | 17 | 21 | 0.6858 |
| Present | 24 | 12 | 12 | |
| Tumor size | ||||
| ≤ 5 cm | 22 | 7 | 15 | 0.04459 |
| > 5 cm | 43 | 25 | 18 | |
| CEA level | ||||
| < 5 µg/mL | 43 | 20 | 23 | 0.5398 |
| ≥ 5 µg/mL | 22 | 12 | 10 | |